Time-to-Market |
|||||||||||||||||||||
|
Increasing partner profitability by radically slashing time-to-market
For medical device manufacturers, time-to-market means time-to-money. After the long investment phase required for developing new medical devices and testing them in rigorous, FDA-compliant clinical trials, companies and their investors are eager to see returns on FDA-approved devices and procedures. However, market introduction of products is too often hampered by delays in the redesign and prototyping process required to optimize the imaging technology that makes the new procedure possible – and/or in moving from prototypes to volume manufacturing, a process that for most traditional endoscope manufacturers averages 2 years or more. The BioVision team has radically slashed the time needed to move from design and redesign to prototypes to volume manufacturing, achieving design to volume manufacturing cycles in, on average, 6-9 months, with prototypes often available for clinical trials in a month or less. We accomplish this radical shortening of the design, prototype, and volume manufacturing cycles via:
|
|
||||||||||||||||||||
| Visualizing better care today; enabling the procedures of tomorrow |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
Content Copyright 2007 BioVision Technologies, LLC Content may not be reproduced without written permission. |
|||||||||||||||||||||